In-vitro study explores the potential of Pomanox® as an ocular anti-inflammatory agent Mollet del Vallès (Spain), May 2023: A recently published study in the Journal of Clinical and Translational Ophthalmology shows the anti-inflammatory effect of Euromed’s Pomanox® in a common cell model for testing eye damage and irritation.[1] This trial suggests for the first time that the pomegranate extract may have potential as an ocular anti-inflammatory agent, which could be promising for the growing … [Read more...] about Pomegranate extract linked to eye health benefits